Quinolinone derivatives as PARP inhibitors
US8404713B2 · kind B2 · utility
7Cited by
15References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2008 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Oct 4, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):wherein R1, R2, R3, R4, R5, Z and n have defined meanings, the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary ammonium salts and the stereochemically isomeric forms thereof, and their use for the treatment of PARP-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.